Shareholder Alert: The Ademi Firm investigates whether KORE Group Holdings Inc. is obtaining a Fair Price for its Public Shareholders [Accessibility Statement] Skip NavigationMILWAUKEE, Feb. 27, 2026 /PRNewswire/ -- Ademi LLP is investigating KORE (NYSE: KORE) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Searchlight Capital Partners and Abry Partners.Click [here] to learn how to join our investigation and obtain additional information or cont ...

Shareholder Alert: The Ademi Firm investigates whether Arcellx Inc. is obtaining a Fair Price for its Public Shareholders [Accessibility Statement] Skip NavigationMILWAUKEE, Feb. 23, 2026 /PRNewswire/ -- Ademi LLP is investigating Arcellx (NASDAQ: ACLX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Leonard Green & Partners.Click [here] to learn how to join our investigation and obtain additional information or contact us at [[email protected]] ...

Group 1 - Ademi LLP is investigating IHS Holding Limited for potential breaches of fiduciary duty and other legal violations related to its transaction with MTN Group Limited [1] - The transaction involves IHS Holding stockholders receiving $8.50 per share in an all-cash deal valued at approximately $6.2 billion in enterprise value [1] - The transaction agreement imposes significant penalties on IHS Holding for accepting competing bids, which raises concerns about the board's fiduciary duties to shareholders [1]

Core Viewpoint - Ademi LLP is investigating Clear Channel for potential breaches of fiduciary duty and other legal violations related to its transaction with Mubadala Capital and TWG Global [1] Group 1: Transaction Details - Clear Channel stockholders will receive $2.43 per share in an all-cash transaction, valuing the company at an enterprise value of $6.2 billion [2] - Clear Channel insiders are set to receive substantial benefits as part of change of control arrangements [2] Group 2: Investigation Focus - The transaction agreement imposes significant penalties on Clear Channel for accepting competing bids, which may limit competing transactions unreasonably [3] - The investigation will assess whether the Clear Channel board of directors is fulfilling their fiduciary duties to all shareholders [3]

Core Viewpoint - Ademi LLP is investigating Webster for potential breaches of fiduciary duty and other legal violations related to its transaction with Banco Santander [1]. Group 1: Transaction Details - Webster stockholders will receive $48.75 in cash and 2.0548 Santander American Depository Shares for each Webster common share, equating to a per-share consideration of approximately $75.59 based on closing prices as of February 2, 2026 [2]. - Webster insiders are set to receive substantial benefits as part of the change of control arrangements [2]. Group 2: Investigation Focus - The transaction agreement imposes significant penalties on Webster if it accepts competing bids, which raises concerns about the board of directors' fulfillment of their fiduciary duties to all shareholders [3].

Core Viewpoint - Fermi Inc. is facing a class action lawsuit due to alleged misleading statements and failures to disclose critical information during its IPO and subsequent trading period, leading to significant stock price declines [1][3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Lupia v. Fermi Inc. and was filed in the Southern District of New York, charging Fermi and its executives with violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 [1][3]. - Investors who purchased Fermi common stock during the IPO or between October 1, 2025, and December 11, 2025, can seek appointment as lead plaintiff by March 6, 2026 [1][6]. - The lawsuit alleges that Fermi overstated tenant demand for its Project Matador campus and failed to disclose reliance on a single tenant's funding commitment, which posed a significant risk [3][4]. Group 2: Financial Impact - Following the announcement that the first tenant for Project Matador terminated a $150 million funding agreement, Fermi's stock price dropped nearly 34% [4]. - The stock price has since fallen to as low as $8.59 per share, representing a 59% decline from the IPO price of $21.00 per share [5]. Group 3: Company Background - Fermi Inc. is described as an energy and AI infrastructure company, having sold 37,375,000 shares at $21.00 each during its October 2025 IPO [2][3]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the investors, is noted for its significant recoveries in securities-related class action cases, having recovered over $2.5 billion for investors in 2024 alone [7].

Core Viewpoint - Richtech Robotics Inc. is facing a class action lawsuit for allegedly misleading investors about its relationship with Microsoft, which has resulted in a significant drop in its stock price [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit, titled Diez v. Richtech Robotics Inc., allows purchasers of Richtech Robotics securities between January 27, 2026, and January 29, 2026, to seek appointment as lead plaintiff by April 3, 2026 [1]. - The lawsuit alleges that Richtech Robotics falsely claimed a commercial relationship with Microsoft during the class period [3]. - Following the publication of an article by Hunterbrook Media on January 29, 2026, which denied any partnership with Microsoft, Richtech Robotics Class B stock fell over 29% within two trading days [4]. Group 2: Company Background - Richtech Robotics develops, manufactures, and sells robotic solutions aimed at automation in the service industry [2]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the investors, is recognized as a leading firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6].

Core Viewpoint - Ademi LLP is investigating Northfield for potential breaches of fiduciary duty and other legal violations related to its transaction with Columbia Financial [1]. Group 1: Transaction Details - Northfield stockholders will receive either shares of the new holding company or cash based on an independent valuation, with specific terms depending on the valuation range [2]. - If the valuation is less than $2.3 billion, shareholders will receive either 1.425 shares or $14.25 in cash; for valuations between $2.3 billion and $2.6 billion, the consideration increases to 1.450 shares or $14.50 in cash; and for valuations of $2.6 billion or higher, shareholders will receive 1.465 shares or $14.65 in cash [2]. - A maximum of 30% of outstanding Northfield shares may be converted to cash, and insiders will receive substantial benefits as part of change of control arrangements [2]. Group 2: Investigation Focus - The transaction agreement imposes significant penalties on Northfield for accepting competing bids, which raises concerns about the board of directors' fulfillment of their fiduciary duties to all shareholders [3].

Core Viewpoint - Coterra is under investigation for potential breaches of fiduciary duty related to its transaction with Devon Energy, which may not be in the best interest of its shareholders [1][3]. Group 1: Transaction Details - Coterra stockholders will receive 0.70 shares of Devon common stock for each Coterra share, resulting in Devon shareholders owning approximately 54% of the combined company and Coterra shareholders holding about 46% on a fully diluted basis [2]. - Coterra insiders are set to receive substantial benefits as part of the change of control arrangements [2]. Group 2: Investigation Focus - The transaction agreement imposes significant penalties on Coterra for accepting competing bids, which raises concerns about the board's fulfillment of fiduciary duties to all shareholders [3].

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant stock price declines following revelations of financial discrepancies [3][4]. Group 1: Allegations and Financial Impact - The lawsuit claims that Ardent Health did not accurately assess the collectability of accounts receivable, which inflated reported financial positions [3]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised accounts receivable assessments, resulting in a nearly 34% drop in stock price [4]. - The company also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing industry-wide cost pressures [4]. Group 2: Legal Process and Representation - Investors who purchased Ardent Health securities during the specified class period can seek to be appointed as lead plaintiff in the class action lawsuit [5]. - The lead plaintiff will represent the interests of all class members and can choose a law firm to litigate the case [5]. Group 3: Company Overview - Ardent Health operates a network of hospitals and clinics providing various healthcare services [2].